Which treatment for patent foramen ovale in cryptogenic stroke?
The management of a patient with a cryptogenic stroke and a patent foramen ovale (PFO) depends on the existence of identifiable causes of stroke, on the PFO characteristics, on the characteristics of the patient, on the contraindications to antithrombotic therapy, and on the preference of the patient. There is no consensus on the management of a patient with a cryptogenic stroke and a PFO, but the algorithm presented in this article seems reasonable to these authors.
Mahé
Isabelle
I
Clinique Thérapeutique, Hôpital Lariboisiére, 2 rue Ambroise Paré, Paris 75010, France. isabelle.mahe@lrb.ap-hop-paris.fr
Caulin
Charles
C
Bergmann
Jean-François
JF